Are You Investing in Monsanto’s Toxic Legacy Without Realizing It? Mutual Funds and Monsanto Stocks

Monsanto didn’t achieve $11.8 billion in sales and 404 facilities in 66 countries all on its own.

The company is valued at $60 billion in the marketplace with 525 million shares outstanding, but the three largest mutual fund shareholders, Vanguard, Fidelity and State Street, own nearly 16 percent of Monsanto stock. By comparison, the seed giant’s CEO Hugh Grant owns less than 1 percent.

This all means there’s a solid chance that the toxic law manipulator may be nestled somewhere in your mutual fund or 401(k) plan. Those findings are part of a six-month investigation by Food Democracy Now! that results in the launch of a global divestment campaign against Monsanto.

Whether it’s by contacting a financial advisor to dump Monsanto investments or strategically opting into funds that aren’t linked to Monsanto or other chemical or biotech companies, the organization is encouraging people around the world to divest.

“Monsanto is a ruthless corporation that operates beyond the ethical boundaries of what is acceptable for a healthy democratic society, said Dave Murphy, founder and Executive Director of Food Democracy Now!, said in a statement. “For decades its executives lied about the harm of its toxic chemicals, intimidated scientists and bullied farmers to put profits over human health and public safety.

“It’s time to broaden socially responsible investing to confront the significant harms that Monsanto has caused.”

The organization likens Monsanto to tobacco corporations like Philip Morris and RJR Reynolds that most never knowingly invest in.

Last year, Monsanto spent $4.5 million in opposition of a Washington State bill to require mandatory labeling of genetically engineered foods. In February, an International Journal of Environmental Research and Public Health study linked Monsanto’s Roundup weed killer to a fatal chronic kidney disease impacting poor farming areas around the world.

Food Democracy bills its campaign as a way for people to stop unknowingly profiting from such activities and stop “financing them as they poison the planet, contaminate our food supply and corrupt our democracy.” Here’s an excerpt from the letter to executives at Fidelity, Vanguard and Street State that the organization is asking people to sign:

“As the manufacturers of Agent OrangeDDT, and PCBs, Monsanto’s corporate executives intentionally ignored the warning of their own scientists for decades regarding the harmful and even deadly effects these products had on their workers, communities where the chemicals were manufactured and even America’s veterans …

Remove Monsanto’s stock from any open-ended fund under your management.

I urge you to take this important step for people and the planet. 

It’s time to take a stand for future generations.”


Articles by: Brandon Baker

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]